Adenovirus type 3 induces platelet activation in vitro

Jin,Ying-Yu; Yu,Xiu-Nan; Qu,Zhang-Yi; Zhang,Ai-Ai; Xing,Yu‑Ling; Jiang,Li-Xin; Shang,Lei; Wang,Ying-Chen

doi:10.3892/mmr.2013.1805

Adenovirus type 3 induces platelet activation in vitro

Authors:
- Ying-Yu Jin
- Xiu-Nan Yu
- Zhang-Yi Qu
- Ai-Ai Zhang
- Yu‑Ling Xing
- Li-Xin Jiang
- Lei Shang
- Ying-Chen Wang
View Affiliations

Affiliations: Department of Hygienic Microbiology, Public Health College, Harbin Medical University, Harbin, Heilongjiang 150081, P.R. China, Department of Laboratory Diagnosis, The First Clinical College, Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China
Published online on: November 15, 2013 https://doi.org/10.3892/mmr.2013.1805
Pages: 370-374

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, we aimed to investigate platelet activation induced by adenovirus type 3 (HAdV3) in vitro. Platelet-rich plasma (PRP) or whole blood was incubated with or without HAdV at various concentrations. Platelet aggregation, platelet counting, fibrinogen and expression of platelet membrane antigens (CD41a and CD62P) were determined following incubation with HAdV for different periods of time. The results demonstrated that HAdV at the concentrations of 109-1011 vp/ml enhanced adenosine diphosphate (ADP) or ristocetin-induced platelet aggregation, however did not alter the platelet count. Infection with HAdVs also reduced fibrinogen level. P-selectin and CD41a appeared rapidly on the surface after platelets were incubated with HAdVs in vitro for 30 min. In conclusion, HAdVs may induce activation of platelets and lead to a pre-thrombotic state of peripheral blood. This finding may aid in the development of measures to prevent severe HAdV infection.

View Figures

View References

1	Picker SM: In-vitro assessment of platelet function. Transfus Apher Sci. 44:305–319. 2011. View Article : Google Scholar : PubMed/NCBI
2	Klinger MH and Jelkmann W: Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 22:913–922. 2002. View Article : Google Scholar : PubMed/NCBI
3	Othman M, Labelle A, Mazzetti I, Elbatarny HS and Lillicrap D: Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. Blood. 109:2832–2839. 2007.PubMed/NCBI
4	Youssefian T, Drouin A, Massé JM, Guichard J and Cramer EM: Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood. 99:4021–4029. 2002. View Article : Google Scholar
5	Senzel L, Gnatenko DV and Bahou WF: The platelet proteome. Curr Opin Hematol. 16:329–333. 2009. View Article : Google Scholar
6	Zhang Y and Bergelson JM: Adenovirus receptors. J Virol. 79:12125–12131. 2005. View Article : Google Scholar : PubMed/NCBI
7	Faraday N, Rade JJ, Johns DC, Khetawat G, Noga SJ, DiPersio JF, Jin Y, Nichol JL, Haug JS and Bray PF: Ex vivo cultured megakaryocytes express functional glycoprotein IIb–IIIa receptors and are capable of adenovirus-mediated transgene expression. Blood. 94:4084–4092. 1999.PubMed/NCBI
8	Triantafilou K, Triantafilou M, Takada Y and Fernandez N: Human parechovirus 1 utilizes integrins alphavbeta3 and alphavbeta1 as receptors. J Virol. 74:5856–5862. 2000. View Article : Google Scholar : PubMed/NCBI
9	Stone D, Liu Y, Shayakhmetov D, Li ZY, Ni S and Lieber A: Adenovirus-platelet interaction in blood causes virus sequestration to the reticuloendothelial system of the liver. J Virol. 81:4866–4871. 2007. View Article : Google Scholar : PubMed/NCBI
10	Eggerman TL, Mondoro TH, Lozier JN and Vostal JG: Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation. Hum Gene Ther. 13:125–128. 2002. View Article : Google Scholar : PubMed/NCBI
11	Gray GC, McCarthy T, Lebeck MG, et al: Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004–2006. Clin Infect Dis. 45:1120–1131. 2007.PubMed/NCBI
12	Lebeck MG, McCarthy TA, Capuano AW, Schnurr DP, Landry ML, Setterquist SF, Heil GL, Kilic S and Gray GC: Emergent US adenovirus 3 strains associated with an epidemic and serious disease. J Clin Virol. 46:331–336. 2009. View Article : Google Scholar : PubMed/NCBI
13	Shang L, Qu Z, Sun L, Wang Y, Liu F, Wang S, Gao H and Jiang F: Astragaloside IV inhibits adenovirus replication and apoptosis in A549 cells in vitro. J Pharm Pharmacol. 63:688–694. 2011. View Article : Google Scholar : PubMed/NCBI
14	Angeles Marcos M, Camps M, Pumarola T, Antonio Martinez J, Martinez E, Mensa J, Garcia E, Peñarroja G, Dambrava P, Casas I, Jiménez de Anta MT and Torres A: The role of viruses in the aetiology of community-acquired pneumonia in adults. Antivir Ther. 11:351–359. 2006.
15	Maurice A, Marchand-Arvier M, Edert D, Le Faou A, Gondrexon G and Vigneron C: The virucidal effect of platelet concentrates: preliminary study and first conclusions. Platelets. 13:219–222. 2002.PubMed/NCBI
16	Basani RB, French DL, Vilaire G, Brown DL, Chen F, Coller BS, Derrick JM, Gartner TK, Bennett JS and Poncz M: A naturally occurring mutation near the amino terminus of alphaIIb defines a new region involved in ligand binding to alphaIIbbeta3. Blood. 95:180–188. 2000.
17	Shimaoka M and Springer TA: Therapeutic antagonists and conformational regulation of integrin function. Nat Rev Drug Discov. 2:703–716. 2003. View Article : Google Scholar : PubMed/NCBI
18	Plow EF, Haas TA, Zhang L, Loftus J and Smith JW: Ligand binding to integrins. J Biol Chem. 275:21785–21788. 2000. View Article : Google Scholar : PubMed/NCBI
19	Yakushkin VV, Zyuryaev IT, Khaspekova SG, Sirotkina OV, Ruda MY and Mazurov AV: Glycoprotein IIb–IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome. Platelets. 22:243–251. 2011.
20	Mazurov AV, Pevzner DV, Antonova OA, Byzova TV, Khaspekova SG, Semenov AV, Vlasik TN, Samko AN, Staroverov II and Ruda MY: Safety, inhibition of platelet aggregation and pharmacokinetics of Fab’2 fragments of the anti-glycoprotein IIb–IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty. Platelets. 13:465–477. 2002.
21	Appledorn DM, Kiang A, McBride A, Jiang H, Seregin S, Scott JM, Stringer R, Kousa Y, Hoban M, Frank MM and Amalfitano A: Wild-type adenoviruses from groups A-F evoke unique innate immune responses, of which HAd3 and SAd23 are partially complement dependent. Gene Ther. 15:885–901. 2008. View Article : Google Scholar : PubMed/NCBI
22	Klinger JR, Sanchez MP, Curtin LA, Durkin M and Matyas B: Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med. 157:645–649. 1998. View Article : Google Scholar : PubMed/NCBI
23	McEver RP, Beckstead JH, Moore KL, Marshall-Carlson L and Bainton DF: GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 84:92–99. 1989. View Article : Google Scholar
24	Denis CV, André P, Saffaripour S and Wagner DD: Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci USA. 98:4072–4077. 2001. View Article : Google Scholar : PubMed/NCBI
25	Sundd P, Pospieszalska MK, Cheung LS, Konstantopoulos K and Ley K: Biomechanics of leukocyte rolling. Biorheology. 48:1–35. 2011.PubMed/NCBI
26	Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA and Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 359:848–851. 1992. View Article : Google Scholar : PubMed/NCBI
27	Blann AD, Nadar SK and Lip GY: The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J. 24:2166–2179. 2003. View Article : Google Scholar : PubMed/NCBI
28	Iannacone M, Sitia G, Narvaiza I, Ruggeri ZM and Guidotti LG: Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clin Vaccine Immunol. 14:1532–1535. 2007. View Article : Google Scholar